UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Align Technology
ALGN
$12.3B
| $2.13M | ﹤0.01% |
39,698
+2,300
| +6% | +$131K |
|
1277
Interparfums
IPAR
$3.94B
| $2.13M | ﹤0.01% |
65,322
-27,731
| -30% | -$774K |
|
1278
PBF Energy
PBF
$7.31B
| $2.13M | ﹤0.01% |
62,741
+9,441
| +18% | +$274K |
|
1279
Leidos
LDOS
$17.3B
| $2.13M | ﹤0.01% |
50,710
+2,434
| +5% | +$106K |
|
|
HSNI
1280
DELISTED
HSN, Inc.
HSNI
| $2.11M | ﹤0.01% |
30,972
+18,573
| +150% | +$1.31M |
|
|
AEC
1281
DELISTED
ASSOCIATED ESTATES REALTY CORP
AEC
| $2.11M | ﹤0.01% |
85,431
-6,600
| -7% | -$162K |
|
1282
Steris
STE
$23.1B
| $2.1M | ﹤0.01% |
29,898
+1,200
| +4% | +$79.2K |
|
1283
Jack in the Box
JACK
$335M
| $2.1M | ﹤0.01% |
21,899
+800
| +4% | +$72.5K |
|
|
PSB
1284
DELISTED
PS Business Parks, Inc.
PSB
| $2.1M | ﹤0.01% |
25,250
+200
| +0.8% | +$16.5K |
|
1285
WaFd
WAFD
$2.75B
| $2.09M | ﹤0.01% |
95,914
+39,118
| +69% | +$825K |
|
1286
American Eagle Outfitters
AEO
$3.01B
| $2.08M | ﹤0.01% |
121,994
+3,300
| +3% | +$50.3K |
|
1287
3D Systems Corp
DDD
$613M
| $2.08M | ﹤0.01% |
75,966
+2,100
| +3% | +$61.8K |
|
1288
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
| $2.08M | ﹤0.01% |
21,839
-48,692
| -69% | -$4.62M |
|
1289
Compañía de Cervecerías Unidas
CCU
$2.21B
| $2.08M | ﹤0.01% |
100,100
| – | – |
|
|
BLCM
1290
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $2.08M | ﹤0.01% |
8,970
-100
| -1% | -$24.2K |
|
|
BRKL
1291
DELISTED
Brookline Bancorp
BRKL
| $2.08M | ﹤0.01% |
206,462
-7,935
| -4% | -$77.2K |
|
1292
Cognex
CGNX
$11.3B
| $2.07M | ﹤0.01% |
83,396
+3,000
| +4% | +$63.8K |
|
|
SFG
1293
DELISTED
STANCORP FINL GRP
SFG
| $2.07M | ﹤0.01% |
30,136
+600
| +2% | +$39.9K |
|
1294
Cabot Corp
CBT
$4.52B
| $2.07M | ﹤0.01% |
45,923
+1,300
| +3% | +$57.4K |
|
1295
iShares International Treasury Bond ETF
IGOV
$1.54B
| – | – |
0
| – | – |
|
1296
Mercado Libre
MELI
$92.3B
| $2.03M | ﹤0.01% |
16,599
+600
| +4% | +$75.8K |
|
1297
Manhattan Associates
MANH
$11.4B
| $2.03M | ﹤0.01% |
40,100
+2,300
| +6% | +$111K |
|
1298
Teledyne Technologies
TDY
$32B
| $2.02M | ﹤0.01% |
18,899
+600
| +3% | +$60.1K |
|
1299
HUB Group
HUBG
$2.92B
| $2.02M | ﹤0.01% |
102,632
-374
| -0.4% | -$7.05K |
|
|
LXK
1300
DELISTED
Lexmark Intl Inc
LXK
| $2.02M | ﹤0.01% |
47,604
+2,500
| +6% | +$103K |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.